NEW YORK (GenomeWeb) – Dutch genetic testing firm GenDx announced on Wednesday that it has received a medical device license from Canadian regulators for its NGSengine human leukocyte antigen (HLA) typing software.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.